Risedronate Sodium Tablet, Film Coated
Product Images NDC 71205-714
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Risedronate Sodium (NDC 71205-714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Risedronatefig4 (Figure4)
Risedronatefig5 (Figure5)
Risedronatefig6 (Figure6)
71205-714-04 (Rise35mgblscarton4tabs)
This is a description of a medication label. The medication is Risedronate Sodium 35mg, which comes in a bottle containing 4 film-coated tablets. The medication is distributed by Proficent Rx LP and relabeled for use. The tablet has "APO" engraved on one side, and "RIS" over "35" on the other side. It is suggested to dispense the enclosed medication guide to each patient. The medication should be stored at 20°-25°C (68°-77°F) and kept out of reach of children. The product ID is SR071404, and the GTIN is 0371205714048. The manufacturer is Apotex Inc. from Toronto, Ontario, Canada.*
Risedronatestructure (Risedronatechemstructure)
Risedronatefig1 (Risedronatefig1)
Risedronatefig2 (Risedronatefig2)
The text is a description of Figure 2 showing the change in BMD (bone mineral density) from baseline to 2-year prevention study. The information includes mean % change and SE (standard error) of BMD for different body parts, such as Lumbar Spine, Femoral Neck, and Trochanter. However, the text also contains non-English characters and errors, which make it difficult to accurately interpret.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.